cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team
Charlotte, North Carolina--(Newsfile Corp. - October 5, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced that it will be the official sponsor of the FIFA-affiliated professional Costa Rican soccer team, Club Sport Herediano. This partnership marks the first and only partnership between a CBD brand and a FIFA-recognized premier division professional soccer team. cbdMD...
2023-10-05 9:00 AM EDT
cbdMD Announces Adjournment of Special Meeting
Charlotte, North Carolina--(Newsfile Corp. - September 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) announced that its Special Meeting of Shareholders that convened on September 22, 2023 has been adjourned until October 26, 2023 at 1:00 p.m. (Eastern Time) to solicit additional proxies for its proposal to approve an amendment to the Company's Certificate of Designation for the Series A Preferred Stock to provide that each share of Series A Preferred Stock will be...
2023-09-22 5:02 PM EDT
Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose
Charlotte, North Carolina--(Newsfile Corp. - September 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's safety data supporting a safe upper dose of its proprietary Broad Spectrum CBD blend. The data was published in Regulatory Toxicology and Pharmacology. The publication includes three separate OECD experiments on rodents...
2023-09-22 9:58 AM EDT
Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023
Charlotte, North Carolina--(Newsfile Corp. - September 14, 2023) - cbdMD, Inc. (NYSE American: YCBD), a highly trusted and recognized cannabidiol (CBD) brand reminds its shareholders to vote ahead of the upcoming special meeting of both Series A preferred as well as common shareholders (the "Meeting") to be held on September 22, 2023 at 1:00 pm (Eastern time). The Board of Directors of cbdMD (the "Board") unanimously recommends that the Company's shareholders vote "FOR" all proposals. Both...
2023-09-14 12:48 PM EDT
Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award
Charlotte, North Carolina--(Newsfile Corp. - August 25, 2023) - The Pet Innovation Awards has announced that cbdMD, Inc. (NYSE American: YCBD), a highly trusted and recognized cannabidiol (CBD) brand, and its pet products brand, Paw CBD, have been honored with the prestigious "Dog Hip & Joint Product of the Year" award for their Hip+Joint Soft Chews in the 2023 awards program. Paw CBD's Hip+Joint Soft Chews provide essential comfort and care for dogs, supporting mobility and enhancing overall...
2023-08-25 9:00 AM EDT
cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock
Charlotte, North Carolina--(Newsfile Corp. - August 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) today announced that its Board of Directors has suspended the monthly cash dividend payment on the Company's 8.0% Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Stock") beginning with the month ending August 31, 2023, as the Company conserves cash in order to continue its efforts to increase sales, develop additional products, continue research...
2023-08-22 8:30 AM EDT
cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products
Washington, D.C.--(Newsfile Corp. - August 18, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced its direct response to the Bicameral and Bipartisan Congressional RFI on FDA Regulation of CBD and urges FDA to provide regulatory clarity. On Thursday, July 27th, following a historic hearing on hemp and CBD held by the House Oversight and Accountability Committee, a...
2023-08-18 2:23 PM EDT
cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million
Charlotte, North Carolina--(Newsfile Corp. - August 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our third quarter of fiscal 2023 results. For the third quarter of fiscal 2023 Net Loss improved to $1.7 million on sales of $6.1 million as compared to a $31.6...
2023-08-10 4:48 PM EDT
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday August 10, 2023, to discuss the company's June 30, 2023 third quarter of fiscal 2023 financial results and business progress. CONFERENCE CALL DETAILS Thursday August 10 2023, 4:30 p.m. Eastern...
2023-08-07 10:00 AM EDT
cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness
Charlotte, North Carolina--(Newsfile Corp. - August 3, 2023) - cbdMD (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the launch of its hemp-derived Delta 9 THC + CBD gummies - UPLIFT, ELEVATE, and RELAX - the brand's first line designed to give you a specific strain-like experience. The new lineup is designed to create a personalized morning to night routine that makes it easier than ever for...
2023-08-03 9:00 AM EDT
cbdMD Announces Migration to E-Commerce Platform, Shopify
Charlotte, North Carolina--(Newsfile Corp. - June 29, 2023) - cbdMD (NYSE American: YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced their e-commerce experience will now be powered by Shopify. cbdMD is committed to improve the customer experience holistically, which starts at the point of purchase. To execute on that commitment, migrating to Shopify and its ever-growing ecosystem and tools will allow the brand to support its growing audience...
2023-06-29 2:25 PM EDT
cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega
Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE American: YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency. As a brand that's renowned for its...
2023-06-22 9:00 AM EDT
cbdMD Stabilizes Revenue and Significantly Improves Operating Results
Charlotte, North Carolina--(Newsfile Corp. - May 15, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands - including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our second quarter of fiscal 2023 results. For the second quarter of fiscal 2023 GAAP Net Loss improved to $1.4 million on sales of $6.2 million as compared to a $5.0...
2023-05-15 4:10 PM EDT
cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress. CONFERENCE CALL DETAILS Monday, May 15, 2023, 4:15 p.m. Eastern TimeUSA/
2023-05-10 2:59 PM EDT
cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock
Charlotte, North Carolina--(Newsfile Corp. - May 3, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the closing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million. Maxim Group LLC...
2023-05-03 2:02 PM EDT
cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock
Charlotte, North Carolina--(Newsfile Corp. - April 30, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the pricing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering are expected to be approximately $2.8 million before deducting underwriting discounts, commissions, and estimated offering...
2023-04-30 8:51 PM EDT
cbdMD Announces Proposed Public Offering of Common Stock
Charlotte, North Carolina--(Newsfile Corp. - April 28, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced it has commenced an underwritten public offering of shares of its common stock. All shares of common stock in the offering are to be sold by cbdMD. In addition, cbdMD intends to grant the underwriter in the offering a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the...
2023-04-28 4:49 PM EDT
cbdMD's Clinical Study Supports Improved Mobility in Dogs
Charlotte, North Carolina--(Newsfile Corp. - April 18, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the results from its canine clinical study conducted at Colorado State University. The clinical study explored the benefits of our core broad spectrum hemp extract in dogs, and the data suggests that daily consumption of the product positively impacted dogs' mobility. To...
2023-04-18 11:50 AM EDT
cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common Stock
Charlotte, North Carolina--(Newsfile Corp. - April 14, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading provider of high-quality CBD products, announced today that its board of directors on April 12, 2023 approved a ratio of one-for-forty five reverse stock split of the Company's issued and outstanding shares of common stock. The Company's shareholders previously approved the reverse stock split on February 16, 2023 and granted the board the authority to determine...
2023-04-14 4:05 PM EDT
cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK
Charlotte, North Carolina--(Newsfile Corp. - April 12, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announces the successful launch of its Novel Food validated premium hemp-derived CBD products on Amazon.co.uk in the United Kingdom ("Amazon UK"). cbdMD gummies, tinctures, and topicals are now available on Amazon UK and qualify for next day delivery through Amazon Prime. The Company is...
2023-04-12 11:57 AM EDT